GSK PLC-SPON ADR (GSK) Institutional Shareholders

GSK PLC-SPON ADR (GSK) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $18.76B in GSK holdings during the latest filing period.

Fmr Llc is currently the largest disclosed institutional shareholder of GSK tracked by InsiderSet, reporting ownership valued at approximately $3.73B in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $3.50B, representing an estimated loss of -6.34% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 70% of the total disclosed GSK value among the investors covered in this analysis. Major shareholders include Fmr Llc, Dodge & Cox Stock Fund, Fisher Asset Management, Llc, and several other long-term asset managers with concentrated positions in GSK PLC-SPON ADR (GSK).

This page ranks the largest institutional GSK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

1,004

Total Reported Value

$18.76B

Largest Holder

Fmr Llc

Largest Position

$3.73B

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

30

Funds Exiting Positions

1

Page 1 of 21
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.20%67,661,646$3,734,246,265$3,497,430,482-$236,815,783-6.34%
Dodge & Cox Stock FundV. D. Dodge, E. M. Cox1.78%58,662,974$3,237,609,535$3,032,289,126-$205,320,409-6.34%
Fisher Asset Management, Llc0.65%34,522,363$1,905,289,284$1,784,460,943-$120,828,341-6.34%
Primecap Management Co/Ca/1.10%25,204,538$1,391,038,453$1,302,822,569-$88,215,884-6.34%
Wellington Management Group Llp0.12%11,717,613$646,695,062$605,683,416-$41,011,646-6.34%
Morgan Stanley0.04%11,030,651$608,781,788$570,174,350-$38,607,438-6.34%
Goldman Sachs Group Inc0.07%9,589,114$529,223,178$495,661,303-$33,561,875-6.34%
Royal Bank Of Canada0.08%7,506,786$414,300,000$388,025,768-$26,274,232-6.34%
State Street Corp0.01%5,998,486$334,022,928$310,061,741-$23,961,187-7.17%
Holocene Advisors, Lp0.74%5,518,433$304,562,317$285,247,802-$19,314,515-6.34%
Mondrian Investment Partners Ltd3.97%4,910,830$257,425,685$253,840,803-$3,584,882-1.39%
Bank Of Montreal0.10%4,639,799$256,070,506$239,831,210-$16,239,296-6.34%
Blackrock, Inc.0.00%3,550,904$195,974,373$183,546,228-$12,428,145-6.34%
Grantham, Mayo, Van Otterloo & Co. Llc0.50%3,522,566$194,410,418$182,081,437-$12,328,981-6.34%
Hotchkis & Wiley Capital Management Llc0.59%3,482,054$192,174,560$179,987,371-$12,187,189-6.34%
Equity Investment Corp3.48%3,221,035$177,768,898$166,495,299-$11,273,599-6.34%
Connor, Clark & Lunn Investment Management Ltd.0.36%2,817,445$155,494,790$145,633,732-$9,861,058-6.34%
Dimensional Fund Advisors Lp0.03%2,586,767$142,763,714$133,709,986-$9,053,728-6.34%
Manufacturers Life Insurance Company, The0.11%2,378,076$131,246,038$122,922,748-$8,323,290-6.34%
Sei Investments Co0.12%2,286,880$126,212,001$118,208,827-$8,003,174-6.34%
Bank Of America Corp0.01%2,206,152$121,757,518$114,035,997-$7,721,521-6.34%
Ubs Group Ag0.02%2,084,235$115,028,930$107,734,107-$7,294,823-6.34%
Envestnet Asset Management Inc0.03%1,837,744$101,425,104$94,992,987-$6,432,117-6.34%
Eversept Partners, Lp6.49%1,785,175$98,523,808$92,275,696-$6,248,112-6.34%
Northern Trust Corp0.01%1,748,557$96,502,861$90,382,911-$6,119,950-6.34%
Bnp Paribas Financial Markets0.06%1,698,298$93,729,067$87,785,024-$5,944,043-6.34%
Letko, Brosseau & Associates Inc1.46%1,644,613$90,766,191$85,010,046-$5,756,145-6.34%
Arrowstreet Capital, Limited Partnership0.05%1,621,397$89,484,900$83,810,011-$5,674,889-6.34%
American Century Companies Inc0.05%1,616,008$89,187,482$83,531,454-$5,656,028-6.34%
Aristotle Capital Management, Llc0.18%1,528,016$84,333,460$78,983,147-$5,350,313-6.34%
Citigroup Inc0.05%1,496,097$82,569,593$77,333,254-$5,236,339-6.34%
Brandes Investment Partners, Lp0.57%1,453,002$80,192,337$75,105,673-$5,086,664-6.34%
Wells Fargo & Company/Mn0.02%1,405,498$77,569,437$72,650,192-$4,919,245-6.34%
Raymond James Financial Inc0.02%1,371,577$75,697,307$70,896,815-$4,800,492-6.34%
Callodine Capital Management, Lp4.90%1,259,477$69,510,536$65,102,366-$4,408,170-6.34%
Mariner, Llc0.08%1,231,009$67,936,168$63,630,855-$4,305,313-6.34%
Alyeska Investment Group, L.P.0.19%1,210,746$66,821,072$62,583,461-$4,237,611-6.34%
Miller Howard Investments Inc1.64%1,182,068$61,963,990$61,101,095-$862,895-1.39%
Russell Investments Group, Ltd.0.06%1,051,317$57,940,604$54,342,576-$3,598,028-6.21%
Lmr Partners Llp0.50%980,479$54,112,636$50,680,960-$3,431,676-6.34%
Franklin Resources Inc0.01%942,429$52,012,655$48,714,155-$3,298,500-6.34%
Douglas Lane & Associates, Llc0.67%946,636$49,622,666$48,931,615-$691,051-1.39%
Lpl Financial Llc0.01%883,997$48,787,795$45,693,805-$3,093,990-6.34%
Bank Of New York Mellon Corp0.01%808,139$44,601,217$41,772,705-$2,828,512-6.34%
Bridgewater Associates, Lp0.17%698,666$38,559,377$36,114,046-$2,445,331-6.34%
First Trust Advisors Lp0.03%682,850$37,686,491$35,296,517-$2,389,975-6.34%
Jane Street Group, Llc0.04%661,399$36,502,611$34,187,714-$2,314,897-6.34%
Crawford Investment Counsel Inc0.60%636,839$35,147,117$32,918,208-$2,228,909-6.34%
Stifel Financial Corp0.03%621,987$34,327,494$32,150,508-$2,176,986-6.34%
Qube Research & Technologies Ltd0.04%548,222$30,256,372$28,337,595-$1,918,777-6.34%

Frequently asked questions about GSK

  • Who owns the most GSK stock?

    The largest holders of GSK are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GSK PLC-SPON ADR (GSK).

  • Is GSK widely held by superinvestors?

    Many widely followed stocks like GSK appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GSK is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.